pre-miRNA Information
pre-miRNA hsa-mir-3679   
Genomic Coordinates chr2: 134127125 - 134127192
Description Homo sapiens miR-3679 stem-loop
Comment None
RNA Secondary Structure

Mature miRNA Information
Mature miRNA hsa-miR-3679-5p
Sequence 6| UGAGGAUAUGGCAGGGAAGGGGA |28
Evidence Experimental
Experiments Illumina
Editing Events in miRNAs
Modification Type Position on miR Chromosome DNA Strand Genomic Position (hg38) List of PMIDs Variant details
A-to-I 17 2 + 134127146 26487287 MiREDiBase
DRVs in miRNA
Mutant ID Mutant Position Mutant Source
COSN28578769 23 COSMIC
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs1490236859 15 dbSNP
rs982355045 16 dbSNP
rs1053094244 17 dbSNP
rs893220051 23 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Gene Information
Gene Symbol EPHA2   
Synonyms ARCC2, CTPA, CTPP1, CTRCT6, ECK
Description EPH receptor A2
Transcript NM_004431   
Expression
Putative miRNA Targets on EPHA2
3'UTR of EPHA2
(miRNA target sites are highlighted)
>EPHA2|NM_004431|3'UTR
   1 GCCTCGACAGGGCCTGGAGCCCCATCGGCCAAGAATACTTGAAGAAACAGAGTGGCCTCCCTGCTGTGCCATGCTGGGCC
  81 ACTGGGGACTTTATTTATTTCTAGTTCTTTCCTCCCCCTGCAACTTCCGCTGAGGGGTCTCGGATGACACCCTGGCCTGA
 161 ACTGAGGAGATGACCAGGGATGCTGGGCTGGGCCCTCTTTCCCTGCGAGACGCACACAGCTGAGCACTTAGCAGGCACCG
 241 CCACGTCCCAGCATCCCTGGAGCAGGAGCCCCGCCACAGCCTTCGGACAGACATATGGGATATTCCCAAGCCGACCTTCC
 321 CTCCGCCTTCTCCCACATGAGGCCATCTCAGGAGATGGAGGGCTTGGCCCAGCGCCAAGTAAACAGGGTACCTCAAGCCC
 401 CATTTCCTCACACTAAGAGGGCAGACTGTGAACTTGACTGGGTGAGACCCAAAGCGGTCCCTGTCCCTCTAGTGCCTTCT
 481 TTAGACCCTCGGGCCCCATCCTCATCCCTGACTGGCCAAACCCTTGCTTTCCTGGGCCTTTGCAAGATGCTTGGTTGTGT
 561 TGAGGTTTTTAAATATATATTTTGTACTTTGTGGAGAGAATGTGTGTGTGTGGCAGGGGGCCCCGCCAGGGCTGGGGACA
 641 GAGGGTGTCAAACATTCGTGAGCTGGGGACTCAGGGACCGGTGCTGCAGGAGTGTCCTGCCCATGCCCCAGTCGGCCCCA
 721 TCTCTCATCCTTTTGGATAAGTTTCTATTCTGTCAGTGTTAAAGATTTTGTTTTGTTGGACATTTTTTTCGAATCTTAAT
 801 TTATTATTTTTTTTATATTTATTGTTAGAAAATGACTTATTTCTGCTCTGGAATAAAGTTGCAGATGATTCAAACCGAAA
 881 AAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' agGGGAA---GGGA---CGGUAUAGGAGu 5'
            :|:||   ||||   |||  |||||| 
Target 5' ctTCTTTAGACCCTCGGGCCCCATCCTCa 3'
476 - 504 133.00 -22.10
2
miRNA  3' aggggAAGGGACGGUAUAGGAGu 5'
               ||:|: |:: | ||||| 
Target 5' atttaTTTCTAGTTCTTTCCTCc 3'
93 - 115 126.00 -11.69
3
miRNA  3' agGGGAAGGGACGGUAUAGGAGu 5'
            |:|   ||  |||| ||||| 
Target 5' acCTCAAGCC--CCATTTCCTCa 3'
390 - 410 125.00 -19.90
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
293404 166 ClinVar
293403 213 ClinVar
293402 224 ClinVar
876693 273 ClinVar
293401 284 ClinVar
293400 297 ClinVar
293399 355 ClinVar
293398 360 ClinVar
293397 443 ClinVar
293396 510 ClinVar
875702 543 ClinVar
293395 624 ClinVar
293394 625 ClinVar
293393 659 ClinVar
293392 668 ClinVar
293391 714 ClinVar
293390 742 ClinVar
293389 790 ClinVar
874766 845 ClinVar
COSN31495633 5 COSMIC
COSN20045328 21 COSMIC
COSN31603959 57 COSMIC
COSN30615848 96 COSMIC
COSN30511368 99 COSMIC
COSN30532999 113 COSMIC
COSN24389720 128 COSMIC
COSN31563035 136 COSMIC
COSN30513221 172 COSMIC
COSN31484355 444 COSMIC
COSN5733160 455 COSMIC
COSN24297937 529 COSMIC
COSN31609837 581 COSMIC
COSN31960181 659 COSMIC
COSN30289789 779 COSMIC
COSN31609559 809 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs1441858816 2 dbSNP
rs770310016 5 dbSNP
rs746296877 6 dbSNP
rs1328353860 8 dbSNP
rs1263732342 9 dbSNP
rs757836462 20 dbSNP
rs747764578 26 dbSNP
rs374568579 27 dbSNP
rs918394523 31 dbSNP
rs754676889 35 dbSNP
rs1318906063 47 dbSNP
rs753511077 48 dbSNP
rs1332128065 49 dbSNP
rs754156201 50 dbSNP
rs1159313860 57 dbSNP
rs1421667478 71 dbSNP
rs1378641059 77 dbSNP
rs1158236404 81 dbSNP
rs1200989700 111 dbSNP
rs1039662473 124 dbSNP
rs972635865 128 dbSNP
rs1189421380 134 dbSNP
rs1006948332 141 dbSNP
rs572073959 142 dbSNP
rs373108711 151 dbSNP
rs904571558 152 dbSNP
rs1262916119 154 dbSNP
rs1283377605 162 dbSNP
rs11543935 166 dbSNP
rs760364834 167 dbSNP
rs1286295102 177 dbSNP
rs1243140536 193 dbSNP
rs1355377451 195 dbSNP
rs1264239568 202 dbSNP
rs755148306 203 dbSNP
rs370184274 206 dbSNP
rs1170642347 209 dbSNP
rs1406152777 211 dbSNP
rs1013637282 212 dbSNP
rs112600002 213 dbSNP
rs1031147847 220 dbSNP
rs886045504 224 dbSNP
rs570719791 227 dbSNP
rs1417001565 230 dbSNP
rs1364315813 236 dbSNP
rs938894319 239 dbSNP
rs550639263 240 dbSNP
rs879192942 244 dbSNP
rs927631917 245 dbSNP
rs1007004561 272 dbSNP
rs1208362952 273 dbSNP
rs1334638980 276 dbSNP
rs537231128 284 dbSNP
rs969554115 285 dbSNP
rs1428056611 293 dbSNP
rs568286286 296 dbSNP
rs1803527 297 dbSNP
rs1036848526 300 dbSNP
rs941194731 303 dbSNP
rs984277368 308 dbSNP
rs951283139 312 dbSNP
rs528206013 313 dbSNP
rs998083422 315 dbSNP
rs1478749159 321 dbSNP
rs1417361028 324 dbSNP
rs372137888 325 dbSNP
rs559346540 327 dbSNP
rs1191398289 332 dbSNP
rs552147972 337 dbSNP
rs916562102 340 dbSNP
rs1018237701 341 dbSNP
rs1200984338 349 dbSNP
rs140956748 355 dbSNP
rs1262636597 357 dbSNP
rs960811007 359 dbSNP
rs41269181 360 dbSNP
rs1043181485 373 dbSNP
rs1440406197 377 dbSNP
rs1331768866 388 dbSNP
rs999735533 393 dbSNP
rs1010722013 400 dbSNP
rs891984989 401 dbSNP
rs1057295370 407 dbSNP
rs1381441438 411 dbSNP
rs1191265374 417 dbSNP
rs938926993 422 dbSNP
rs1383336209 425 dbSNP
rs1238479721 427 dbSNP
rs1022980057 431 dbSNP
rs1479871302 433 dbSNP
rs113810531 443 dbSNP
rs889460750 444 dbSNP
rs1211474321 455 dbSNP
rs1314506161 460 dbSNP
rs1450416987 461 dbSNP
rs1044757627 465 dbSNP
rs1354673521 469 dbSNP
rs1050745554 484 dbSNP
rs947788043 491 dbSNP
rs909533787 502 dbSNP
rs983916095 503 dbSNP
rs896948419 504 dbSNP
rs144559615 510 dbSNP
rs1036732037 512 dbSNP
rs918438601 516 dbSNP
rs976526542 522 dbSNP
rs1244186360 531 dbSNP
rs1380471238 538 dbSNP
rs561159937 547 dbSNP
rs1444804130 548 dbSNP
rs941206204 553 dbSNP
rs909676961 555 dbSNP
rs965266981 557 dbSNP
rs1460398212 559 dbSNP
rs1018185554 562 dbSNP
rs985772370 579 dbSNP
rs968776397 580 dbSNP
rs1210167764 586 dbSNP
rs1488664036 590 dbSNP
rs1288364650 593 dbSNP
rs1237117098 596 dbSNP
rs1316607552 597 dbSNP
rs1181210271 601 dbSNP
rs541085522 602 dbSNP
rs1228743667 603 dbSNP
rs1357217219 608 dbSNP
rs1481617976 614 dbSNP
rs948636431 621 dbSNP
rs917142351 622 dbSNP
rs886045503 624 dbSNP
rs886045502 625 dbSNP
rs368994858 639 dbSNP
rs1360406765 657 dbSNP
rs572208071 658 dbSNP
rs139754494 659 dbSNP
rs1003003580 662 dbSNP
rs1425929726 667 dbSNP
rs146367469 668 dbSNP
rs1044687963 670 dbSNP
rs1187891355 671 dbSNP
rs942265546 679 dbSNP
rs1022430584 680 dbSNP
rs1393767560 684 dbSNP
rs1485663147 691 dbSNP
rs576390680 692 dbSNP
rs557194943 693 dbSNP
rs536963349 696 dbSNP
rs1297086125 697 dbSNP
rs1221960796 703 dbSNP
rs796156874 713 dbSNP
rs78569898 714 dbSNP
rs1029866772 730 dbSNP
rs1297077023 734 dbSNP
rs1380090283 737 dbSNP
rs1383711796 738 dbSNP
rs539294758 741 dbSNP
rs111512184 742 dbSNP
rs879068624 747 dbSNP
rs918296109 755 dbSNP
rs748903065 756 dbSNP
rs534862493 760 dbSNP
rs1232976007 774 dbSNP
rs1164721914 779 dbSNP
rs1466590645 780 dbSNP
rs1015298936 781 dbSNP
rs943907724 789 dbSNP
rs1005278659 790 dbSNP
rs371642899 790 dbSNP
rs565773014 791 dbSNP
rs948542654 794 dbSNP
rs985415362 803 dbSNP
rs895777501 806 dbSNP
rs969014089 806 dbSNP
rs1421380721 807 dbSNP
rs1248567786 808 dbSNP
rs1325368901 809 dbSNP
rs1021638836 814 dbSNP
rs1442606714 815 dbSNP
rs578205829 815 dbSNP
rs1325647421 816 dbSNP
rs978182536 821 dbSNP
rs552021933 837 dbSNP
rs946847502 840 dbSNP
rs181703453 845 dbSNP
rs956757299 846 dbSNP
rs1219991862 856 dbSNP
rs532111236 867 dbSNP
rs1358379520 876 dbSNP
rs956113132 877 dbSNP
rs1035817591 879 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions TZM-bl
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL ...

- Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' agGGGAA---GGGA---CGGUAUAGGAGu 5'
            :|:||   ||||   |||  |||||| 
Target 5' -uUCUUUAGACCCUCGGGCCCCAUCCUCa 3'
1 - 28
Article - Whisnant AW; Bogerd HP; Flores O; Ho P; et al.
- mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
Experimental Support 2 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HCT116
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in ERX177621. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_3_11 PAR-CLIP data was present in ERX177609. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_2_11 PAR-CLIP data was present in ERX177605. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_2_7 PAR-CLIP data was present in ERX177606. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_2_8 PAR-CLIP data was present in ERX177610. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_2_12 PAR-CLIP data was present in ERX177617. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_3_7 PAR-CLIP data was present in ERX177618. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_3_8 PAR-CLIP data was present in ERX177620. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_3_10 PAR-CLIP data was present in ERX177622. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_3_12 PAR-CLIP data was present in ERX177629. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_4_7 PAR-CLIP data was present in ERX177630. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_4_8 PAR-CLIP data was present in ERX177632. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_4_10 PAR-CLIP data was present in ERX177633. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_4_11 PAR-CLIP data was present in ERX177634. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_4_12 ...

- Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research.

Article - Krell J; Stebbing J; Carissimi C; Dabrowska et al.
- Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
CLIP-seq Support 1 for dataset GSM1462574
Method / RBP PAR-CLIP / AGO2
Cell line / Condition TZM-bl / TZM-bl ami BaL
Location of target site ENST00000358432.5 | 3UTR | UUCUUUAGACCCUCGGGCCCCAUCCUCAUCCCUGACUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23592263 / GSE59944
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
HNSC 0.977 0.07 1.000 0.5 3 Click to see details
THCA 0.972 0.08 1.000 0.5 3 Click to see details
STAD 0.962 0.09 0.500 0.33 3 Click to see details
LUSC -0.834 0.19 -0.500 0.33 3 Click to see details
LUSC -0.834 0.19 -0.500 0.33 3 Click to see details
LUSC -0.834 0.19 -0.500 0.33 3 Click to see details
LUSC -0.834 0.19 -0.500 0.33 3 Click to see details
LUSC -0.834 0.19 -0.500 0.33 3 Click to see details
LUSC -0.834 0.19 -0.500 0.33 3 Click to see details
55 hsa-miR-3679-5p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT114494 PNN pinin, desmosome associated protein 2 2
MIRT169967 DNAJB9 DnaJ heat shock protein family (Hsp40) member B9 2 6
MIRT182181 POU2F1 POU class 2 homeobox 1 2 2
MIRT189380 TXLNA taxilin alpha 2 4
MIRT364735 TOR1B torsin family 1 member B 2 2
MIRT445477 KDM6A lysine demethylase 6A 2 2
MIRT446333 ATP5C1 ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 2 2
MIRT446386 SYNCRIP synaptotagmin binding cytoplasmic RNA interacting protein 2 2
MIRT446971 SLCO4C1 solute carrier organic anion transporter family member 4C1 2 2
MIRT449793 C1orf109 chromosome 1 open reading frame 109 2 2
MIRT451211 PIN1 peptidylprolyl cis/trans isomerase, NIMA-interacting 1 2 2
MIRT452098 NUCB2 nucleobindin 2 2 2
MIRT454036 DDT D-dopachrome tautomerase 2 2
MIRT461708 ZNF426 zinc finger protein 426 2 2
MIRT464957 TWIST1 twist family bHLH transcription factor 1 2 2
MIRT465775 TMOD3 tropomodulin 3 2 2
MIRT466925 STC2 stanniocalcin 2 2 2
MIRT471388 PDPR pyruvate dehydrogenase phosphatase regulatory subunit 2 2
MIRT473585 MAT2A methionine adenosyltransferase 2A 2 2
MIRT476070 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A 2 2
MIRT477324 EPHA2 EPH receptor A2 2 2
MIRT478244 DDX3X DEAD-box helicase 3, X-linked 2 4
MIRT480449 C16orf72 chromosome 16 open reading frame 72 2 6
MIRT481866 ANKRD50 ankyrin repeat domain 50 2 2
MIRT492032 TSG101 tumor susceptibility 101 2 4
MIRT493737 GRAP2 GRB2-related adaptor protein 2 2 2
MIRT495623 PPP1R1C protein phosphatase 1 regulatory inhibitor subunit 1C 2 2
MIRT497590 SLC23A1 solute carrier family 23 member 1 2 2
MIRT504702 ZNF117 zinc finger protein 117 2 2
MIRT507794 CDKN1B cyclin dependent kinase inhibitor 1B 2 2
MIRT510653 TMED7 transmembrane p24 trafficking protein 7 2 4
MIRT525534 FSIP2 fibrous sheath interacting protein 2 2 2
MIRT531149 CYGB cytoglobin 2 2
MIRT536003 MED13 mediator complex subunit 13 2 2
MIRT537056 GPR180 G protein-coupled receptor 180 2 2
MIRT538297 CSNK2A1 casein kinase 2 alpha 1 2 2
MIRT544755 C8orf33 chromosome 8 open reading frame 33 2 2
MIRT544927 MIS18BP1 MIS18 binding protein 1 2 2
MIRT556973 HSPA4L heat shock protein family A (Hsp70) member 4 like 2 2
MIRT561714 PPP2R2A protein phosphatase 2 regulatory subunit Balpha 2 2
MIRT563632 ZNF460 zinc finger protein 460 2 2
MIRT564705 ZNF322P1 zinc finger protein 322 pseudogene 1 2 2
MIRT572190 CALU calumenin 2 2
MIRT573900 MKI67 marker of proliferation Ki-67 2 2
MIRT576073 Poteg POTE ankyrin domain family, member G 2 2
MIRT576150 Hmox1 heme oxygenase 1 2 2
MIRT614848 PLEKHA6 pleckstrin homology domain containing A6 2 4
MIRT647592 FAM109B family with sequence similarity 109 member B 2 2
MIRT657009 KCNMB4 potassium calcium-activated channel subfamily M regulatory beta subunit 4 2 2
MIRT691268 GET4 golgi to ER traffic protein 4 2 2
MIRT695778 DENR density regulated re-initiation and release factor 2 2
MIRT698089 TPM1 tropomyosin 1 2 2
MIRT732571 IGLL5 immunoglobulin lambda like polypeptide 5 1 0
MIRT733722 NEDD4L neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase 3 0
MIRT734354 GREM1 gremlin 1, DAN family BMP antagonist 1 0
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-3679-5p 5-Fluorouracil approved 3385 Microarray CNE cells 22614822 2012 up-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-3679 Doxorubicin 31703 NSC123127 approved sensitive High Hepatocellular Carcinoma cell line (HepG2)
hsa-miR-3679-5p Platinum 23939 sensitive High Ovarian Cancer tissue
hsa-miR-3679-5p Doxorubicin 31703 NSC123127 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-miR-3679-5p Curcumin 969516 NSC32982 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-miR-3679-5p Osimertinib 71496458 NSC779217 approved resistant Low Non-Small Cell Lung Cancer tissue
hsa-miR-3679-5p Etoposide 36462 NSC141540 approved resistant High Colorectal Cancer cell line (HCT8)
hsa-miR-3679-5p Doxorubicin 31703 NSC123127 approved resistant High Colorectal Cancer cell line (HCT8)
hsa-miR-3679-5p Paclitaxel 36314 NSC125973 approved resistant High Colorectal Cancer cell line (HCT8)
hsa-miR-3679-5p Vinorelbine 44424639 approved resistant High Colorectal Cancer cell line (HCT8)
hsa-miR-3679-5p Vincristine 5978 approved resistant High Colorectal Cancer cell line (HCT8)
hsa-miR-3679-5p Gefitinib 123631 NSC715055 approved sensitive cell line (PC9)
hsa-miR-3679-5p Gefitinib 123631 NSC715055 approved sensitive cell line (HCC827)
hsa-miR-3679-5p Osimertinib 71496458 NSC779217 approved sensitive cell line (HCC827)
hsa-miR-3679-5p Paclitaxel 36314 NSC125973 approved resistant cell line (BAS)
hsa-miR-3679-5p Osimertinib 71496458 NSC779217 approved resistant cell line (H1975)
hsa-miR-3679-5p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-3679-5p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM16)
hsa-miR-3679-5p Gemcitabine 60750 NSC613327 approved resistant cell line (PANC-1) (1500 ng/ml)
hsa-miR-3679-5p Gemcitabine 60750 NSC613327 approved resistant cell line (PANC-1) (100 ng/ml)

Error report submission